sorel combo 50 mikrogramov/500 mikrogramov v 1 g mazilo
lek d.d. - betametazon; kalcipotriol - mazilo - betametazon 500 µg / 1 g kalcipotriol50 µg / 1 g; kalcipotriol 50 µg / 1 g - kalcipotriol, kombinacije
xamiol 50 mikrogramov/500 mikrogramov v 1 g gel
leo pharma a/s - betametazon; kalcipotriol - gel - betametazon 500 µg / 1 g kalcipotriol50 µg / 1 g; kalcipotriol 50 µg / 1 g - kalcipotriol, kombinacije
daivonex 50 mikrogramov/g mazilo
pharmagan, d.o.o. - kalcipotriol - mazilo - kalcipotriol 50 µg / 1 g - kalcipotriol
daivonex 50 mikrogramov/g krema
pharmagan, d.o.o. - kalcipotriol - krema - kalcipotriol 50 µg / 1 g - kalcipotriol
ibuem 250 mg/250 mg/50 mg tablete
sanofi-aventis d.o.o. - acetilsalicilna kislina; kofein; paracetamol - tableta - acetilsalicilna kislina 250 mg / 1 tableta kofein50 mg / 1 tableta paracetamol250 mg / 1 tableta; kofein 50 mg / 1 tableta paracetamol250 mg / 1 tableta; paracetamol 250 mg / 1 tableta - paracetamol, kombinacije brez psiholeptikov
rosuvastatin mylan 10 mg filmsko obložene tablete
mylan ireland limited - rosuvastatin - filmsko obložena tableta - rosuvastatin 10 mg / 1 tableta - rosuvastatin
rosuvastatin mylan 20 mg filmsko obložene tablete
mylan ireland limited - rosuvastatin - filmsko obložena tableta - rosuvastatin 20 mg / 1 tableta - rosuvastatin
rosuvastatin mylan 40 mg filmsko obložene tablete
mylan ireland limited - rosuvastatin - filmsko obložena tableta - rosuvastatin 40 mg / 1 tableta - rosuvastatin
imuran 50 mg filmsko obložene tablete
pharmasan d.o.o. - azatioprin - filmsko obložena tableta - azatioprin 50 mg / 1 tableta - azatioprin
azacitidine mylan
mylan ireland limited - azacitidin - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - antineoplastična sredstva - azacitidine mylan is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with:intermediate 2 and high risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29% marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30% blasts and multi lineage dysplasia, according to world health organisation (who) classification,aml with > 30% marrow blasts according to the who classification.